Cite
HARVARD Citation
Nordmaj, M. et al. (2015). Genetically engineered fusion of MAP‐1 and factor H domains 1–5 generates a potent dual upstream inhibitor of both the lectin and alternative complement pathways. FASEB journal. 29 (12), pp. 4945-4955. [Online].